The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

In a 5-4 decision, the justices said that Sackler family members could not be shielded from liability for civil claims related to the opioid epidemic. The original settlement would have required ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, replaces a ...

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, replaces a ...